Style | Citing Format |
---|---|
MLA | Arjmand B, et al.. "Discovering Tumor Microenvironment Dynamics in Hpv-Associated Cancers: Using Organoid-Based Models to Develop Therapeutics." Regenerative Engineering and Translational Medicine, vol. , no. , 2025, pp. -. |
APA | Arjmand B, Najafi G, Alavimoghadam S, Arjmand R, Rezaeitavirani M, Keshtkari S, Larijani B (2025). Discovering Tumor Microenvironment Dynamics in Hpv-Associated Cancers: Using Organoid-Based Models to Develop Therapeutics. Regenerative Engineering and Translational Medicine, (), -. |
Chicago | Arjmand B, Najafi G, Alavimoghadam S, Arjmand R, Rezaeitavirani M, Keshtkari S, Larijani B. "Discovering Tumor Microenvironment Dynamics in Hpv-Associated Cancers: Using Organoid-Based Models to Develop Therapeutics." Regenerative Engineering and Translational Medicine , no. (2025): -. |
Harvard | Arjmand B et al. (2025) 'Discovering Tumor Microenvironment Dynamics in Hpv-Associated Cancers: Using Organoid-Based Models to Develop Therapeutics', Regenerative Engineering and Translational Medicine, (), pp. -. |
Vancouver | Arjmand B, Najafi G, Alavimoghadam S, Arjmand R, Rezaeitavirani M, Keshtkari S, et al.. Discovering Tumor Microenvironment Dynamics in Hpv-Associated Cancers: Using Organoid-Based Models to Develop Therapeutics. Regenerative Engineering and Translational Medicine. 2025;():-. |
BibTex | @article{ author = {Arjmand B and Najafi G and Alavimoghadam S and Arjmand R and Rezaeitavirani M and Keshtkari S and Larijani B}, title = {Discovering Tumor Microenvironment Dynamics in Hpv-Associated Cancers: Using Organoid-Based Models to Develop Therapeutics}, journal = {Regenerative Engineering and Translational Medicine}, volume = {}, number = {}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Arjmand B AU - Najafi G AU - Alavimoghadam S AU - Arjmand R AU - Rezaeitavirani M AU - Keshtkari S AU - Larijani B TI - Discovering Tumor Microenvironment Dynamics in Hpv-Associated Cancers: Using Organoid-Based Models to Develop Therapeutics JO - Regenerative Engineering and Translational Medicine VL - IS - SP - EP - PY - 2025 ER - |